Regulation of glucose homeostasis by glucocorticoids
Glucocorticoids are steroid hormones that regulate multiple aspects of glucose homeostasis.
Glucocorticoids promote gluconeogenesis in liver, whereas in skeletal muscle and white …
Glucocorticoids promote gluconeogenesis in liver, whereas in skeletal muscle and white …
Glucocorticoids and cancer
MA Pufall - Glucocorticoid Signaling: From Molecules to Mice to …, 2015 - Springer
Unlike other steroid hormone receptors, the glucocorticoid receptor (GR) is not considered
an oncogene. In breast cancer, the estrogen receptor (ER) drives cell growth, proliferation …
an oncogene. In breast cancer, the estrogen receptor (ER) drives cell growth, proliferation …
Strategy of targeting the tumor microenvironment via inhibition of fibroblast/fibrosis remodeling new era to cancer chemo-immunotherapy resistance
M Tajaldini, A Poorkhani, T Amiriani, A Amiriani… - European Journal of …, 2023 - Elsevier
The use of repurposing drugs that may have neoplastic and anticancer effects increases the
efficiency and decrease resistance to chemotherapy drugs through a biochemical and …
efficiency and decrease resistance to chemotherapy drugs through a biochemical and …
Advantages and drawbacks of dexamethasone in glioblastoma multiforme
The most widespread, malignant, and deadliest type of glial tumor is glioblastoma
multiforme (GBM). Despite radiation, chemotherapy, and radical surgery, the median …
multiforme (GBM). Despite radiation, chemotherapy, and radical surgery, the median …
[HTML][HTML] Novel PET imaging of inflammatory targets and cells for the diagnosis and monitoring of giant cell arteritis and polymyalgia rheumatica
Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are two interrelated
inflammatory diseases affecting patients above 50 years of age. Patients with GCA suffer …
inflammatory diseases affecting patients above 50 years of age. Patients with GCA suffer …
[HTML][HTML] Overcoming glucocorticoid resistance in acute lymphoblastic leukemia: repurposed drugs can improve the protocol
Glucocorticoids (GCs) are a central component of multi-drug treatment protocols against T
and B acute lymphoblastic leukemia (ALL), which are used intensively during the remission …
and B acute lymphoblastic leukemia (ALL), which are used intensively during the remission …
[HTML][HTML] Control of T cell metabolism by cytokines and hormones
Dynamic, coordinated changes in metabolic pathway activity underpin the protective and
inflammatory activity of T cells, through provision of energy and biosynthetic precursors for …
inflammatory activity of T cells, through provision of energy and biosynthetic precursors for …
PPARα and fatty acid oxidation mediate glucocorticoid resistance in chronic lymphocytic leukemia
S Tung, Y Shi, K Wong, F Zhu… - Blood, The Journal …, 2013 - ashpublications.org
High-dose glucocorticoids (GCs) can be a useful treatment for aggressive forms of chronic
lymphocytic leukemia (CLL). However, their mechanism of action is not well understood, and …
lymphocytic leukemia (CLL). However, their mechanism of action is not well understood, and …
[HTML][HTML] ENO2 promotes cell proliferation, glycolysis, and glucocorticoid-resistance in acute lymphoblastic leukemia
C Liu, H Wang, W Wang, L Wang, W Liu… - Cellular Physiology and …, 2018 - karger.com
Background/Aims: The metabolic features of cancer cells have long been acknowledged to
be altered and to provide new therapeutic opportunities. The expression of glycolytic …
be altered and to provide new therapeutic opportunities. The expression of glycolytic …
[HTML][HTML] Dexamethasone-induced fatty acid oxidation and autophagy/mitophagy are essential for T-ALL glucocorticoid resistance
M Olivas-Aguirre, J Pérez-Chávez, L Torres-López… - Cancers, 2023 - mdpi.com
Simple Summary Reduced response to glucocorticoids (GCs, such as dexamethasone,
Dex), first-line drugs employed during therapy induction, is considered a poor prognosis …
Dex), first-line drugs employed during therapy induction, is considered a poor prognosis …